zurück | HD 3, Deutsche Hodkin Studiengruppe |
|||
Stadium |
fortgeschrittene Stadien | |||
Fragestellung |
Konsolidierung nach erfolgreicher Induktion | |||
Ergebnis |
Kein signifikanter Unterschied zwischen RT und COPP + ABVD | |||
Induktion |
3 x (COPP + ABVD) | |||
Random |
20Gy IF-RT | |||
COPP + ABVD | ||||
Quellen |
1.) Loeffler M, et al.: Dose-response relationship of complimentary radiotherapy following four cycles of combination chemotherapy in intermeiate - stage Hodgkin's disease. JCO 15(1997):2275-2287 Diehl V, Pfreundschuh M, Loeffler M, et al: Chemotherapy of Hodgkin’s lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastin, and dacarbazine): Results of the HD1 and HD3 trials of the German Hodgkin Study Group. Med Oncol Tumor Pharmacother 6:155-162, 1989 | |||
|
Impressum .....................................................................................Zuletzt geändert am 30.08.2013 18:23